Innovative ADCC and ADCP Technologies and Services for Cell Therapies and Therapeutic Antibodies
In this webinar, you will learn about:
- Implementing the HiBiT Target Cell Killing platform for a sensitive, specific, and consistent read-out of effector cell function
- Measuring ADCC and ADCP using HiBiT TCK Bioassays
- Evaluating Fc-mediated antibody functions for early discovery programs
Summary
Speakers
Julia Gilden, PhD
Senior Research Scientist
Promega
David Cobeta Lopez, MSc
Scientist
Charles River Laboratories
Leiden, The Netherlands